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Introduction
Bone is the most common site for metastases, and bone 
metastases occur frequently in advanced cancer patients 
(Coleman, 2006), particularly in patients with breast, 
prostate, lung, and renal cell cancers, of whom 40% to 
70% will eventually develop bone metastases (Coleman, 
2006; Costa et al., 2008). Hence, clinicians should care for 
bone metastases in most cancer patients who frequently 
have bone pain or other significant complications such 
as spinal cord or nerve root compression, hypercalcemia 
or pathological fractures. As a result, their quality of life 
(QoL) is hugely jeopardized (Coleman, 2000; Costa et 
al., 2008). 
QoL is one of the ultimately treatment endpoints for 
patients with bone metastases, as clinical trials reflect 
the importance of QoL (Chow and Bottomley, 2009; 
Zeng et al., 2012). Specifically, a recent survey updating 
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Abstract
 Background: The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 
Bone Metastases Module (EORTC QLQ-BM22) is a recently designed supplement to EORTC Quality of Life 
Questionnaire-C30 (EORTC QLQ-C30). Additional psychometric properties, especially using confirmatory 
factor analysis (CFA) and the Rasch model, are warranted. Materials and Methods: A total of 573 patients 
with bone metastases were enrolled from eight countries with a mean±SD age of 55.8±13.7 years. Slightly more 
than two thirds of them were female (n=383; 66.8%). CFA was used to examine the BM22 framework; Rasch 
models were applied to understand misfit items and differential item functioning (DIF). Results: The fit indices 
were satisfactory in CFA (comparative fit index=0.972, Tucker-Lewis index=0.964, root mean square error of 
approximation=0.076, and standardized root mean square residual=0.045). All items fit well in the Rasch models 
(mean square values were between 0.5 and 1.5), and only one item (number 17) displayed DIF across gender. 
However, there were six DIF items across Canada and Taiwan, ten across Canada and Iran, and six across 
Taiwan and Iran. Conclusions: The BM22 has satisfactory psychometric properties, and could assess the QoL of 
patients with bone metastases specifically focusing on their symptoms. Clinicians may want to use it to capture 
the underlying QoL for patients with bone metastases. However, the score of item 17 should be interpreted with 
caution when comparing male and female patients. In addition, researchers should note that variation in DIF 
items may occur when conducting an international study. 
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the international consensus on palliative radiotherapy 
endpoints for clinical trials in bone metastases stated that 
91% of the interviewed radiation oncologists agreed the 
importance of incorporating a validated QoL instrument 
(Chow et al., 2012a). Furthermore, a general questionnaire 
for all cancer patients (e.g., the European Organisation 
for Research and Treatment of Cancer Quality of Life 
Questionnaire-C30 [EORTC QLQ-C30]) lacks the ability 
to fully evaluate the specific aspects of QoL for patients 
with bone metastases (Chow and Bottomley, 2009). 
Therefore, the EORTC Bone Metastases Module (EORTC 
QLQ-BM22 or BM22) was designed as a supplement to 
the EQRTC QLQ-C30, and help clinicians to fully capture 
the QoL of a patient with bone metastases (Chow and 
Bottomley, 2009). 
Although the BM22 was developed using sound 
methodology in accordance with the EORTC Quality of 
Life Group guidelines (Chow and Bottomley, 2009), we 
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feel that psychometric properties are still insufficient for 
clinicians to use it. Specifically, the validation studies on 
BM22 (Chow et al., 2012b; Puskulluoglu et al., 2014; 
Yekaninejad et al., 2014) did not concern the wording 
effects (i.e., BM22 contains positively- and negatively-
worded items) and primary used classical test theory 
(CTT). CTT is often criticized by its inappropriate 
treatment on scoring methods, such as means and standard 
deviations, and it does not focus on item parameters 
(i.e. item difficulty). Moreover, CTT relies on person 
parameters which depend on instrument items. Therefore, 
it is inappropriate to compare different instruments or 
populations using the CTT approach (Hobart and Cano, 
2009). 
Contrarily, Rasch model, a modern psychometric 
model belonged to the item-response theory (IRT) family, 
separately assesses person ability and item difficulty 
(DeRoos and Allen-Meares, 1993). Person ability refers 
to an individual’s degree of a trait while item difficulty is 
the degree of a trait as determined by the item (DeRoos 
and Allen-Meares, 1993; Amin et al., 2012; Suhonen et 
al., 2013). Respondents with high person ability have a 
higher probability of success on a task than those with low 
person ability (DeRoos and Allen-Meares, 1993; Binda 
et al., 2013). In addition, Rasch can assess the validity 
for each individual item (i.e., testing the redundant and 
out-of-concept items), the threshold order of each item 
response, and differential item functioning (DIF) (Amin 
et al., 2012; Khan et al., 2013). The DIF items occurred 
when two groups (e.g., male and female) interpret the 
item differently. Therefore, it is important for clinicians to 
know which items display DIF. Also, researchers need to 
know which items display DIF across countries to make 
a valid international comparison.
The purpose of this study was to extend the knowledge 
of psychometric properties for BM22. In addition to some 
analyses using CTT, we used confirmatory factor analysis 
(CFA) to additionally account for the wording effect 
issue. We also applied Rasch models to evaluate the item 
difficulty, unfit items, disordered item responses, and DIF 
items for BM22. 
Materials and Methods
Participants
We pooled and analyzed the data from two studies 
on psychometric evaluation of the EORTC QLQ-BM22 
(Chow et al., 2012b; Yekaninejad et al., 2014). The 
participants recruitment procedure is detailed reported 
in the two studies (Chow et al., 2012b; Yekaninejad et 
al., 2014). In sum, our participants were those with bone 
metastases undergoing various treatments across eight 
countries (West countries: Canada, Brazil, France; East 
countries: India, Cyprus, Taiwan, Egypt, and Iran) with 
ten centers: Toronto, Ontario and Edmonton, Alberta 
(Canada); Kerala (India); Nicosia (Cyprus); Sao Paulo 
(Brazil); Taipei and Kaohsiung (Taiwan); Tanta (Egypt); 
Saint Etienne (France); Tehran (Iran). The recruitment 
periods were from March 2010 to January 2011 and from 
April 2012 to March 2013. Identical eligibility criteria 
for both recruitments were (1) patients > 18 years, (2) 
histologically confirmed primary cancer, (3) radiological 
evidence of bone metastases, and (4) patients with the 
cognitively capability to complete the questionnaire in 
the respective languages (Chow et al., 2012b; Yekaninejad 
et al., 2014). All patients completed the EORTC QLQ-
BM22 and a background information sheet (including 
sociodemographic and clinical characteristics) at baseline 
prior to treatment. 
Questionnaire: EORTC QLQ-BM22
The EORTC QLQ-BM22 (BM22) is a 22-item 
questionnaire, developed as a supplement to EORTC 
QLQ-C30. All items are 4-point Likert scale from 1 
(not at all) to 4 (very much), and the items are grouped 
into four domains: painful site (BMPS; 5 items), painful 
characteristic (BMPC; 3 items), functional interference 
(BMFI; 8 items) and psychosocial aspects (BMPA; 6 
items). Scores of items 21 and 22 need to be reversed 
before calculating a 0-100 scale score: higher scores on 
BMPS, BMPC, and BMPA indicate poorer QoL; on BMFI 
indicate better functional ability (Fayers et al., 2001; Chow 
et al., 2012b). 
The BM22 was translated into eight languages 
(Arabic, English, French, Greek, Malayalam, Mandarin 
for Taiwan, Farsi for Iran, and Portuguese for Brazil) of 
the participating countries based on EORTC translation 
guidelines. The processes included two individual forward 
translations, two individual backwards translations, and 
adequate pilot tests (Dewolf et al., 2009). 
Statistical analysis 
After reversely coding the items 21 and 22, we used the 
Figure 1. (a) Confirmatory factor analysis (CFA) 
with four-correlated-trait framework; (b) CFA with 
four-correlated-trait and two-correlated-method 
framework. Abbreviations: CFI=comparative fit 
index; TLI=Tucker-Lewis index; RMSEA=root mean 
square error of approximation; SRMR=standard 
root mean square residual; BMPS=painful sites; 
BMPC=painful characteristics; BMFI=functional 
interference; BMPA=psychosocial aspects
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BM22 raw scores to examine the ceiling and floor effects, 
internal consistency, confirmatory factor analysis (CFA), 
and Rasch models. The ceiling effects for domain and total 
scores of BM22 were reported using the percentages of 
the maximum response (i.e., the percentages of answering 
4), floor effects using those of the minimum response. 
Based on Lin et al. (2013), we defined the ceiling and 
floor effects <3% as negligible, < 5% as minimal, and < 
20% as moderate. The internal consistency was reported 
using Cronbachs’ α, of which > 0.7 suggests satisfactory 
(Chang et al., 2014a). 
In addition to using CFA to test the original framework 
of BM22 (see Figure 1a), we additionally tested another 
framework of BM22, which simultaneously accounting 
for trait and wording effects (see Figure 1b). Because 
BM22 contains two kinds of wording (two positively-
worded items and twenty negatively-worded items), it is 
reasonable to test the data-model fit of a correlated-trait 
(i.e., four domains of BM22) correlated-method (i.e., 
positive and negative wordings) framework (Lin et al., 
2014). Because all absolute skewness (0.071 to 1.257) < 3 
and absolute kurtosis (0.154 to 1.321) <8 (Kline, 2005), we 
used the full information maximum likelihood estimation 
for the two CFA models. The fit indices for satisfactory 
data-model fit were nonsignificant χ2, comparative fit 
index (CFI) and Tucker-Lewis index (TLI) > 0.9, root 
mean square error of approximation (RMSEA) and 
standardized root mean square residual (SRMR) < 0.08 
(Cheng et al., In press). 
Rasch rating scale models were used to separately 
examine the unidimensionality of the four domains. 
Information-weighted fit statistic (infit) mean square 
(MnSq) and outlier-sensitive fit statistic (outfit) MnSq 
were used to determine whether an item is redundant to 
(infit or outfit MnSq < 0.5) or outside (infit or outfit MnSq 
> 1.5) the underlying concept (Lin et al., 2015). Moreover, 
the Rasch models provide separation reliability to estimate 
the reproducibility of the difficult hierarchy separately 
for the items and respondents. Unlike the traditional 
Cronbach’s α, the person separation reliability is not 
affected by the item characteristics, and vice versa. Rasch 
models also provide separation index, which estimates 
the heterogeneity of the items’ difficulty and respondents’ 
ability. The recommended separation reliability is >0.7, 
and separation index is >2 (Chang et al., 2014b). In 
addition, we used average difficulty of each category, 
step difficulty of each threshold or boundary between 
categories, and infit and outfit MnSq to examine the 
expected order. We anticipated monotonically increased 
average and step difficulties with infit and outfit MnSq 
between 0.5 and 1.5 (Jafari et al., 2012). 
Rasch models tested the differential item functioning 
(DIF) for BM22 in terms of the following groups: 
gender (male vs. female) and countries (Canada, Taiwan, 
and Iran). The reason that we tested DIF for the three 
countries is because we need a sufficient sample size for 
each country, and a minimum of 200 is warranted based 
on a simulation study (Scott et al., 2009). However, 
some suggest that a sample size between 100 and 200 is 
somewhat acceptable (Lai et al., 2005). As a result, we 
decided using those countries with a sample size > 100 to 
detect DIF. In addition, the DIF contrast (the difficulty for 
Group 1 minus the difficulty for Group 2) >0.5 indicates 
a substantial DIF (Scott et al., 2009; Lin et al., 2015).
The CFA models were performed using LISREL 8.7 
(Scientific Software International, Lincolnwood, IL, 
USA); Rasch using WINSTEPS (Linacre and Wright, 
2009); all other analyses using SPSS 15.0 (SPSS Inc., 
Chicago, IL, USA). 
Results 
The eligible respondents were 117 in Canada, 11 in 
Egypt, 6 in France, 12 in Brazil, 19 in Cyprus, 224 in 
Taiwan, 7 in India, and 177 in Iran. Their mean±SD age 
was 55.81±13.69 years, and slightly more than two thirds 
of the participants were female (n=383; 66.8%). 
The ceiling and floor effects for all domains of BM22 
were negligible to moderate (ceiling effect: 0.5% to 3.5%; 
floor effect: 0.9% to 19.7%), and there were no ceiling 
and floor effects for the total score. Cronbach’s α was 
acceptable for all domains and the total score (0.72 to 
0.93), except for the BMPS domain (0.68). In addition, 
separation reliability was satisfactory for item separation 
(0.97 to 0.99) but not for person separation (0.55 to 0.85), 
and a similar trend was found in separation index (item 
separation=6.02 to 9.13; person separation=1.11 to 2.40) 
(Table 1).
The fit indices of CFA for the four-trait-correlated 
framework were all adequate, except for a slightly high 
value of RMSEA (0.100). The framework simultaneously 
accounting for the trait and method effects (i.e., the four-
Table 1. Internal Consistency, Separation Reliability and Separation Indices of BM22
 Domain    BM22
 BMPS BMPC BMFI BMPA 
Item No. 5 3 8 6 22
Classical test theory     
Ceiling % 0.50% 2.10% 3.50% 1.00% 0.00%
Floor % 8.40% 19.70% 8.70% 0.90% 0.00%
Cronbach’s α 0.68 0.77 0.93 0.72 0.93
Rasch      
Person separation index 1.11 1.38 2.4 1.39 --
Person separation reliability 0.55 0.66 0.85 0.66 --
Item separation index 6.02 7.93 5.54 9.13 --
Item separation reliability 0.97 0.98 0.97 0.99 --
BMPS=painful sites; BMPC=painful characteristics; BMFI=functional interference; BMPA=psychosocial aspects
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trait-correlated and two-method-correlated framework) 
had all fit indices satisfactory (Figure 1). In addition, the 
standardized factor loadings of all items were reported 
on Table 2.
All items had acceptable Rasch fit statistics in terms 
of infit and outfit MnSq, and their item difficulties fell 
between -0.56 to 0.56 for BMPS; -0.69 to 0.87 for BMPC; 
-0.60 to 0.56 for BMFI; -0.67 to 1.06 for BMPA (Table 
2). If we additionally considered the step difficulties, 
the difficulty ranges were -2.36 to 2.28 for BMPS; 
-3.37 to 3.22 for BMPC; -3.15 to 3.01 for BMFI; -2.14 
to 2.15 for BMPA. Moreover, all the step difficulties 
were monotonically increased by their categories with 
satisfactory infit and outfit MnSq (Table 3). 
Only item 17 (Felt isolated from those close to 
you) displayed substantial DIF across gender (DIF 
contrast=-0.53). However, six substantial DIF items were 
found across Canada and Taiwan, ten across Canada and 
Iran, and six across Taiwan and Iran (Table 2). In addition, 
items 16 (Had to modify your daily activities because of 
your illness) and 17 displayed substantial DIF across the 
three countries. 
Discussion
The satisfactory internal consistency, including 
Cronbach’s α and item separation reliability, agrees 
with previous studies (Chow et al., 2012b; Yekaninejad 
et al., 2014). Therefore, the BM22 items are reliable 
for measuring QoL for patients with bone metastases. 
In addition, the low ceiling and floor effects, adequate 
fit indices in CFA models, good fit statistics in Rasch 
Table 2. Confirmatory Factor Analysis (CFA) Standardized Factor Loadings and Rasch Difficulties and Rasch 
Fit Statistics for Each Item
Domain CFA Rasch DIF contrast
Item # and description Loadings Difficulties Infit 
MnSq
Outfit 
MnSq
Male vs. 
Female
Canada vs. 
Taiwan
Canada 
vs. Iran
Taiwan 
vs. Iran
BMPS (Painful sites)
1. Pain in your back 0.63 -0.56 0.93 0.93 0 -0.46 -0.70 -0.23
2. Pain in your leg(s) or hips(s) 0.62 -0.25 1.09 1.08 -0.18 -0.43 -0.20 0.22
3. Pain your arm(s) or shoulder(s) 0.46 0.13 0.99 1.01 0.09 0.58 0.75 0.17
4. Pain in your chest or rib(s) 0.55 0.12 0.96 0.95 0.26 0.56 0.16 -0.40
5. Pain in your buttock(s) 0.58 0.56 1.12 1.03 -0.15 -0.12 0.2 0.31
BMPC (Painful characteristics)
6. Had constant pain 0.82 -0.17 0.94 0.92 -0.10 -0.09 0.46 0.55
7. Had intermittent pain 0.67 -0.69 1.08 1.06 0.4 0.29 -0.83 -1.12
8. Had pain not relieved by pain 
medications 0.66 0.87 1.02 0.92 -0.35 -0.30 0.36 0.66
BMFI (Functional interference)
9. Had pain while lying down 0.76 0.44 1.05 1 0.17 0.43 0.11 -0.32
10. Had pain while sitting 0.77 0.56 0.79 0.83 0.1 0.1 -0.58 -0.67
11. Had pain when trying to stand up 0.78 0.26 0.85 0.82 -0.09 -0.03 -0.51 -0.48
12. Had pain while walking 0.81 0.2 0.84 0.84 0.06 0.17 0.02 -0.15
13. Had pain with activities such as 
bending or climbing stairs 0.8 -0.32 0.85 0.85 0.03 0.01 0.34 0.34
14. Had pain with strenuous activity 
(e.g., exercise, lifting)
0.71 -0.59 0.93 0.89 -0.09 0.04 0.47 0.43
15. Has pain interfered with sleeping at 
night 0.72 0.05 1.23 1.24 0.06 0.62 0.9 0.28
16. Had to modify your daily activities 
because of your illness 0.67 -0.60 1.43 1.48 0.26 -1.17 -0.67 0.51
BMPA (Psychosocial aspects)
17. Felt isolated from those close to you 
(e.g., family, friends) 0.54 1.06 1.23 1.1 -0.53 -1.33 0.51 1.84
18. Worried about loss of mobility 
because of your illness 0.85 0 0.78 0.75 -0.18 -0.39 -0.38 0.01
19. Worried about becoming dependent 
on others because of your illness 0.84 -0.06 0.76 0.76 0 -0.36 -0.66 -0.29
20. Worried about your health in the 
future 0.68 -0.67 0.76 0.77 0.08 -0.07 -0.49 -0.42
21. Felt hopeful your pain will get better 0.29 -0.19 1.29 1.3 0.42 1.32 0.97 -0.34
22. Felt positive about your health 0.24 -0.15 1.27 1.33 0.1 0.24 0.02 -0.22
Infit MnSq=information-weighted fit statistic mean square; Outfit MnSq=outlier-sensitive fit statistic mean square; DIF=differential item functioning. 
DIF contrast=Difficulty of the former group (e.g., male) subtracts difficulty of the later group (e.g., female). Substantial DIF contrasts are in bold.
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models, and anticipated response ordering suggest that 
the psychometric properties of the BM22 are sound. 
Although the person separation index and reliability were 
low, and some DIF items were found, we feel that these 
are acceptable. 
The low person separation index indicates that our 
sample was homogeneous in QoL, and low person 
separation reliability indicates unstable QoL performance 
(Chang et al., 2014b; Lin et al., 2015). However, the 
BM22 items had heterogeneous difficulties and stable item 
properties as indicated by our high item separation index 
and reliability. In addition, our results confirm the findings 
of Yekaninejad et al. (2014) that the framework of BM22 is 
valid. We additionally extend their findings that a slightly 
wording effect was found in the framework of BM22. A 
questionnaire containing both positively- and negatively-
worded items may influence its psychometric properties 
(Lin et al., 2014) and our study found the impacts, though 
not substantial, in the BM22. Nevertheless, our results 
indicated that the construct of BM22 is supported. 
An interesting finding is the DIF items in BM22. DIF 
occurs when the groups interpret the same item differently 
(Lin et al., 2015), and makes comparing DIF items across 
groups meaningless. Therefore, the clinicians should keep 
in mind that which items can be and which cannot be 
compared across certain groups. According to our results, 
all BM22 items but item 17 (Felt isolated from those 
close to you) were interpreted similarly across male and 
female patients with bone metastases. The DIF contrast 
was -0.53, which indicates that female patients tended 
to rate a higher score than did male patients on item 17 
when both gender patients have the same isolated feeling. 
Some DIF items were found across Canada, Taiwan, and 
Iran. Nearly half of the BM22 items displayed DIF across 
Canada and Iran, while only six items were DIF across 
Canada and Taiwan, and across Taiwan and Iran. This 
may due to their cultures: Taiwan and Iran share some 
Asian values; Taiwan is a more westernization society than 
Iran is. As a result, Canadians and Iranians interpret most 
BM22 items differently. Another possibility is the lack of 
translation equivalence (Scott et al., 2010) though we are 
confident that it might impact little on the DIF because 
the translation process is robust and sound (Dewolf et al., 
2009). In addition, we adopted the DIF contrast of 0.5, 
which represents an odds ratio of 1.65, as substantial DIF. 
Therefore, the DIF items displayed in our results could 
be attributable to both culture differences and, if there 
was, the lack of translation equivalence. Nevertheless, 
future studies are warranted to examine the impacts of 
culture differences in the DIF items after accounting for 
the translation equivalence. 
The strength of this study is the international 
recruitment and the use of advanced psychometric 
methods. However, one major limitation of this study is 
no criterion was applied to test the concurrent validity of 
the BM22. 
In conclusion, the BM22 is a sound instrument 
to assess the QoL for patients with bone metastases 
specifically on their symptoms. Clinicians could use it to 
well understand the underlying QoL in terms of painful 
sites, painful characteristics, functional interference, and 
psychosocial aspects for patients with bone metastases. 
However, they need to interpret the score of item 17 with 
cautions when comparing male and female patients. 
References
Amin L, Rosenbaum P, Barr R, et al (2012). Rasch analysis of 
the PedsQL: an increased understanding of the properties of 
a rating scale. J Clin Epidemiol, 65, 1117-23.
Binda D, Vanhoutte EK, Cavaletti G, et al (2013). Rasch-built 
Overall Disability Scale for patients with chemotherapy-
induced peripheral neuropathy (CIPN-R-ODS). Eur J 
Cancer, 49, 2910-8.
Chang CC, Wu TH, Chen CY, et al (2014a). Psychometric 
evaluation of the internalized stigma of mental illness scale 
for patients with mental illnesses: measurement invariance 
across time. PLoS One, 9, 98767.
Chang KC, Wang JD, Tang HP, et al (2014b). Psychometric 
evaluation, using Rasch analysis, of the WHOQOL-
BREF in heroin-dependent people undergoing methadone 
maintenance treatment: further item validation. Health Qual 
Life Outcomes, 12, 148.
Cheng CP, Luh WM, Yang AL, et al (In press). Agreement of 
children and parents scores on Chinese version of Pediatric 
Quality of Life Inventory 4.0: further psychometric 
development. Appl Res Qual Life.
Chow E, Bottomley A (2009). Understanding the EORTC QLQ-
BM22, the module for patients with bone metastases. Expert 
Rev Pharmacoecon Outcomes Res, 9, 461-5.
Chow E, Hoskin P, Mitera G, et al (2012a). Update of the 
international consensus on palliative radiotherapy endpoints 
for future clinical trials in bone metastases. Int J Radiat 
Oncol Biol Phys, 82, 1730-7.
Chow E, Nguyen J, Zhang L, et al (2012b). International field 
testing of the reliability and validity of the EORTC QLQ-
BM22 module to assess health-related quality of life in 
patients with bone metastases. Cancer, 118, 1457-65.
Coleman RE (2000). Management of bone metastases. 
Oncologist, 5, 463-70.
Coleman RE (2006). Clinical features of metastatic bone disease 
and risk of skeletal morbidity. Clin Cancer Res, 12, 6243-9.
Costa L, Badia X, Chow E, et al (2008). Impact of skeletal 
complications on patients’ quality of life, mobility, and 
functional independence. Support Care Cancer, 16, 879-89.
DeRoos YS, Allen-Meares P (1993). Rasch analysis. J Soc Serv 
Res. 161-7.
Dewolf L, Koller M, Velikova G, et al 2009. Translation 
procedure, brussels, belgium, EORTC Quality of Life Group.
Fayers P, Aaronson NK, Bjordal K, et al 2001. The EORTC 
QLQC30 Scoring Manual, Brussels, Belgium, European 
Organization for Research and Treatment of Cancer.
Hobart J, Cano S (2009). Improving the evaluation of therapeutic 
interventions in multiple sclerosis: the role of new 
psychometric methods. Health Technol Assess, 13, 1-177.
Jafari P, Bagheri Z, Safe M (2012). Item and response-category 
functioning of the Persian version of the KIDSCREEN-27: 
Rasch partial credit model. Health Qual Life Outcomes, 
10, 127.
Khan A, Chien CW, Brauer SG (2013). Rasch-based scoring 
offered more precision in differentiating patient groups in 
measuring upper limb function. J Clin Epidemiol, 66, 681-7.
Kline RB 2005. Principles and practice of structural equation 
modeling, New York, Guilford Press.
Lai JS, Teresi J, Gershon R (2005). Procedures for the analysis 
of differential item functioning (DIF) for small sample sizes. 
Eval Health Prof, 28, 283-94.
Lin CY, Luh WM, Cheng CP, et al (2014). Evaluating the 
Chung-Ying Lin and Amir H Pakpour
Asian Pacific Journal of Cancer Prevention, Vol 17, 20161410
0
25.0
50.0
75.0
100.0
N
ew
ly
 d
ia
gn
os
ed
 w
ith
ou
t 
tr
ea
tm
en
t 
N
ew
ly
 d
ia
gn
os
ed
 w
ith
 t
re
at
m
en
t 
Pe
rs
is
te
nc
e 
or
 r
ec
ur
re
nc
e
Re
m
is
si
on
N
on
e
Ch
em
ot
he
ra
py
Ra
di
ot
he
ra
py
Co
nc
ur
re
nt
 c
he
m
or
ad
ia
tio
n
10.3
0
12.8
30.025.0
20.310.16.3
51.7
75.0
51.1
30.031.3
54.2
46.856.3
27.625.0
33.130.031.3
23.7
38.0
31.3
N
ew
ly
 d
ia
gn
os
ed
 w
ith
ou
t 
tr
ea
tm
en
t 
N
ew
ly
 d
ia
gn
os
ed
 w
ith
 t
re
at
m
en
t 
Pe
rs
is
te
nc
e 
or
 r
ec
ur
re
nc
e
Re
m
is
si
on
N
on
e
Ch
em
ot
he
ra
py
Ra
di
ot
he
ra
py
Co
nc
ur
re
nt
 c
he
m
or
ad
ia
tio
n
wording effect and psychometric properties of the Kid-
KINDL: using the multitrait-multimethod approach. Eur J 
Psychol Assess, 30, 100-9.
Lin CY, Luh WM, Cheng CP, et al (2013). Measurement 
equivalence across child self-reports and parent-proxy 
reports in the Chinese version of the pediatric quality of 
life inventory version 4.0. Child Psychiatry Hum Dev, 44, 
583-90.
Lin CY, Yang SC, Lai WW, et al (2015). Rasch models suggested 
the satisfactory psychometric properties of the World Health 
Organization Quality of Life-Brief among lung cancer 
patients. J Health Psychol.
Linacre JM, Wright BD 2009. A user’s guide to WINSTEPS, 
chicago, MESA Press.
Puskulluoglu M, Tomaszewski KA, Bottomley A, et al (2014). 
Validation of the polish version of the EORTC QLQ-BM22 
module for the assessment of health-related quality of life 
in patients with bone metastases. Qual Life Res, 23, 527-32.
Scott NW, Fayers PM, Aaronson NK, et al (2009). A simulation 
study provided sample size guidance for differential 
item functioning (DIF) studies using short scales. J Clin 
Epidemiol, 62, 288-95.
Scott NW, Fayers PM, Aaronson NK, et al (2010). Differential 
item functioning (DIF) analyses of health-related quality of 
life instruments using logistic regression. Health Qual Life 
Outcomes, 8, 81.
Suhonen R, Schmidt LA, Katajisto J, et al (2013). Cross-cultural 
validity of the individualised care scale - a rasch model 
analysis. J Clin Nurs, 22, 648-60.
Yekaninejad MS, Ahmadzadeh A, Mosavi SH, et al (2014). The 
reliability and validity of the iranian version of the european 
organization for research and treatment of cancer quality 
of life questionnaire for patients with bone metastases: the 
EORTC QLQ-BM22. Expert Rev Pharmacoecon Outcomes 
Res, 14, 147-56.
Zeng L, Chow E, Bedard G, et al (2012). Quality of life after 
palliative radiation therapy for patients with painful bone 
metastases: results of an international study validating the 
EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys, 84, 
337-42.
